Use of thrombolytic treatment in patients with acute myocardial infarction in Spain. Observations from the PRIAMHO study;Utilizacion de la trombolisis en los pacientes con infarto agudo de miocardio en Espana: Observaciones del estudio PRIAMHO

Revista Espanola de Cardiologia

Volumn 53, Issue 4, 2000, Pages 490-501

  Boscha, Xavier ^a,b   Sambola, Antonia ^a,b   Arós, Fernando ^c   López Bescós, Lorenzo ^d   Mancisidor, Xabier ^e   Illa, Jaume ^f   Claramonte, Ramón ^g  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital Clínic   (Spain)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL DEL MAR   (Spain)

^g HOSPITAL VERGE DE LA CINTA   (Spain)

Author keywords

Mortality; Myocardial infarction; Registries; Thrombolysis

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; Q WAVE; ST SEGMENT; SURVIVAL; TREATMENT OUTCOME; COHORT ANALYSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REGISTER; SPAIN; TIME; UTILIZATION REVIEW;

AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; SPAIN; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0034168020     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(00)75118-9     Document Type: Article

References (36)

1. Gruppo Italiano per lo studio della Streptochinasi nell'infarto miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. A randomized trial of intravenous streptokinase, oral aspirine, both or neither among 17, 187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-360.
3. LATE study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759-766.
4. The GUSTO Investigators. An International randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
5. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322.
6. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM et al. ACC/AHA Guidelines For the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on management of acute myocardial infarction). Circulation 1996; 94: 2.341-2.350.
7. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43-63.
8. Bosch X, Ferńandez Avilés F, Bermejo García J, Curós A, Valentín V. Tratamiento del infarto agudo de miocardio no complicado. Rev Esp Cardiol 1994; 47 (Supl 1): 9-26.
9. Arós F, Loma-Osorio. A, Alonso A, Alonso JJ, Cabadés A, Coma-Canella I et al. Guías de actuación clínica de la Sociedad Española de Cardiología en el infarto agudo de miocardio. Rev Esp Cardiol 1999; 52: 919-956.
10. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT et al, for the participants in the National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States (1990-1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994; 90: 2103-2114.
11. Danchin N, Vaur L, Genès N, Renault M, Ferrières J, Etienne S et al. Management of acute myocurdial infarction in intensive cars units in 1995: a nationwide french survey of practice and early hospital results. J Am Coll Cardiol 1997; 30: 1598-1605.
12. Venturini F, Romero M, Tognoni G, on behalf of the SIFO/ESCP study group on acute myocardial infarction management. Patterns of practice for acute myocardial infarction in a population from ten countries. Eur J Clin Pharmacol 1999; 54: 877-886.
13. O'Connor GT, Quinton HB, Traven ND, Ramunno LD, Dodds TA, Marciniak TA et al. Geographic variation in the treatment of acute myocardial infarction. The Cooperative Cardiovascular Project. JAMA 1999; 281: 627-633.
14. Barren HV, Rundle A, Gurwitz J, Tiefenbrunn A. Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. Cardiol Rev 1999; 7: 156-160.
15. Brophy JM, Joseph L, Theroux P. Medical decision making in the choice of a thrombolytic agent for acute myocardial infartion. Quebec Acute Coronary Care Working Group. Med Decis Making 1999; 19: 411-418.
16. Wagner S, Scheider S, Schiele R, Fischer F, Dehn H, Grube R et al. Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the myocardial infarction registry (MIR) in Germany. Z Kardiol 1999; 88: 857-867.
17. Cabadés A, Val s F, Echanove I Francés M, Sanjuán R, Calabuig J et al. Estudio RICVAL. El infarto de miocardio en la ciudad de Valencia. Datos de 1.124 pacientes en los primeros 12 meses del Registro (diciembre de 1993-noviembre de 1994). Rev Esp Cardiol 1997; 50: 3983-3996.
18. Cabadés A, Echanove I, Cebrián J, Cardona J, Valls F, Parra V et al, en representación de los investigadores del PRIMVAC. Características, manejo y pronóstico del patiente con infarto de miocardio en la Comunicad Valenciana en 1995: resultados del registro PRIMVAC (Prcyecto de Registro de Infarto Agudo de Miocardio de Valencia Alicante y Castellón). Rev Esp Cardiol 1999; 52: 123-133.
19. Cabadés A, López-Bescós L, Arós F, Loma-Osorio A, Bosch X, Pabón P et al. Variabilidad en el manejo y pronóstico a corto y medio plazo del infarto agudo de miocardio en España: el estudio PRIAMHO. Rev Esp Cardiol 1999; 52: 767-775.
20. Golberg RJ, Gurwitz JH, Gore JM. Duration of, and temporal trends (1994-1997) in prehospital delay in patients with acute myocardial infarction: the Second National Registry of Myocardial Infarction. Arch Intern Med 1999; 159: 2141-2147.
21. Torrado González E, Férriz Martín JA, Vera Almazán A, álvarez Bueno M, Rodríguez García JJ, González Rodríguez-Villasonte P et al. Tratamiento trombolítico del infarto agudo de miocardio en el área de urgencias. Rev Esp Cardiol 1997; 50: 689-695.
22. Birkhead JS. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992; 305: 445-448.
23. MacCallum AG, Stafford PJ, Jones C, Vicent R, Pérez-ávila C, Chamberlain DA. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J 1990; 11 (Supl F): 48-52.
24. Pell ACH, Miller HC, Robertson CE, Fox KA. Effect of «fast track» admission for acute myocardial infarction on delay to thrombolysis. Br Med J 1992; 304: 83-86.
25. Moses HW, Bartolozzy JJ, Koester DL, Colliver JA, Taylor GI, Mikell FL et al. Reducing delay in the emergency room in administration of thrombolytic therapy for myocardial infartion associated with ST elevation. Am J Cardiol 1991; 68: 251-253.
26. Sitges M, Bosch X, Sanz G, Heras M, Miranda F, Anguera I et al. Mejoría del tratamiento del infarto agudo de miocardio mediante la creación de una unidad de trombólisis en el servicio de cardiología. Rev Esp Cardiol 1998; 51: 732-739.
27. Burns JM, Hogg KJ, Rae AP, Hillis WS, Dunn FG. Impact of a policy of direct admission to a Coronary Care Unit on use of thrombolytic treatment. Br Heart J 1989; 61: 322-325.
28. Bosch X, López A. Efecto del tratamiento trombolítico sobre el pronóstico del infarto de miocardio en el sexo femenino. Rev Esp Cardiol 1994; 47: 32-39.
29. Lambrew CT, Bowlby LJ, Rogers WJ, Chandra NC, Weaver WD. Factors influencing the time to thrombolysis in acute myocardial infarction. Arch Intern Med 1997; 157: 2577-2582.
30. Bosch X. Desde la torre de marfil a las trincheras. La precocidad llega a la unidad coronaria. Rev Esp Cardiol 1998; 51: 199-203.
31. Kereiakes DJ, Weaver WD, Andcrson JL, Feldman T, Gibier B, Aufderheide T et al. Time delays in the diagnosis and treatment of acute myocurdial infarction: a tale of eight cities. Report from the Prehospital Study Group and the Cincinnati Heart Project. Am Heart J 1990; 120: 773-780.
32. Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS et al, for the myocardial infarction triage and interventions project investigators. The association between on-site cardiac catheterization facilities and the use of coronary angiography after myocardial infarction. N Engl J Med 1993; 329: 546-551.
33. Gil M, Marrugat J, Sala J, Masià R, Elosua R, Albert X et al, and the REGICOR investigators. Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. Circulation 1999; 99: 1763-1773.
34. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy, GUSTO-1 Investigators. J Am Coll Cardiol 1996; 27: 1646-1655.
35. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Raja-kangas AM, Pajak A. WHO MONICA Project. Myocardial infarction coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and casefatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
36. Pérez G, Pena A, Sala J, Roset PN, Masià R, Marrugat J, and the REGICOR Investigators. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in the province of Gerona, Spain 1990 to 1992. Int J Epidemiol 1998; 27: 599-604.